Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002791 · ClinicalTrials.gov registry record · Phase 2
Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002791 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group.
The verdict
NCT00002791, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with more than one chemotherapy drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus radiation therapy followed by surgery in treating patients who have soft tissue sarcoma.
Interventions
- DRUG ifosfamide
- DRUG dacarbazine
- BIOLOGICAL filgrastim
- DRUG doxorubicin hydrochloride
- DRUG mesna
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-02 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002791
The ClinicalTrials.gov registry entry for NCT00002791 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which ifosfamide is the first listed.
NCT00002791 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002791 about?
NCT00002791 is a clinical study titled "Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with more than one chemotherapy drug may kill more tumor cells. PURPOSE: Phase II tria...
What is the current status of trial NCT00002791?
This trial is currently completed. It is a Phase 2 study. The study started on 1997-02. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00002791?
The interventions under investigation include: ifosfamide (DRUG), dacarbazine (DRUG), filgrastim (BIOLOGICAL), doxorubicin hydrochloride (DRUG), mesna (DRUG).
Who is sponsoring clinical trial NCT00002791?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.